13F Holdings
中文EN

SRTA Strata Critical Medical, Inc.

Transportation Services · Nasdaq · SEC CIK 1779128 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY68.4%
TTM net income YoY-161.4%
TTM EPS YoY-160.0%
Revenue 3-yr CAGR9.2%
Net income 3-yr CAGR—

Margins

Gross margin21.6%
Operating margin-6.6%
Net margin-8.8%
FCF margin0.3%
EBITDA margin-3.2%

Returns

ROE-8.9%
ROA-7.5%
ROIC (approx.)-5.9%
Asset turnover0.85x

Leverage & solvency

Liabilities / assets16.0%
Debt / equity0.00x
Current ratio2.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.43x
Accruals ratio-10.7%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-09-30
Income statement
Revenue$197.14M$146.82M$225.18M$146.12M$50.53M
Cost of revenue$156.01M$117.23M$183.06M$123.84M$40.01M
Gross profit$41.13M$29.59M$42.12M$22.27M$10.52M
SG&A expense$60.88M$50.86M$95.17M$62.51M$30.14M
Operating income-$22.35M-$22.52M-$68.12M-$53.53M-$24.09M
Pretax income-$20.07M-$16.16M-$57.54M-$28.03M-$43.70M
Income tax$0$0-$1.47M-$772,000-$3.64M
Net income$41.35M-$27.31M-$56.08M-$27.26M-$40.05M
EBITDA-$14.17M-$16.56M-$61.01M-$47.80M-$23.26M
EPS (basic)0.50-0.35-0.76-0.38-0.93
EPS (diluted)0.50-0.35-0.76-0.38-0.93
Weighted avg. shares (diluted)82.09M77.50M73.52M71.24M42.88M
Banking
Net interest income—$7.21M$8.44M$3.43M$460,000
Balance sheet
Cash & equivalents$31.23M$19.65M$29.02M$44.42M$6.95M
Short-term investments$30.26M$108.76M$138.26M$150.74M$297.18M
Receivables$39.96M$19.82M$21.00M$10.88M$3.77M
Current assets$126.19M$160.74M$206.26M$218.13M$314.45M
PP&E, net$36.44M$28.46M$2.90M$2.04M$1.96M
Goodwill$88.21M$15.54M$13.33M$39.45M$13.27M
Intangibles$47.50M$7.96M$20.52M$46.37M$12.64M
Total assets$325.47M$256.68M$294.94M$325.02M$343.39M
Current liabilities$19.79M$22.73M$35.49M$26.61M$9.53M
Long-term debt———$0—
Total debt———$0—
Total liabilities$46.40M$34.74M$60.64M$50.54M$52.16M
Shareholders' equity$279.07M$221.94M$234.30M$274.49M$291.23M
Net debt———-$44.42M—
Cash flow statement
Operating cash flow-$48.91M-$2.52M-$32.35M-$37.13M-$15.62M
Capital expenditure$9.60M$30.86M$2.11M$730,000$297,000
Free cash flow-$58.51M-$33.38M-$34.46M-$37.86M-$15.91M
Investing cash flow$69.75M-$1.02M$17.09M$79.34M-$321.34M
Financing cash flow-$8.91M-$5.76M-$76,000-$1.08M$332.26M
Depreciation & amortization$8.19M$5.96M$7.11M$5.72M$830,000
Stock-based compensation$17.83M$19.89M$12.50M$8.28M$9.62M
Share buybacks$0$244,000$0——

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.